After hitting a regulatory roadblock in 2022, Sanofi’s consumer healthcare business Opella has secured the FDA’s blessing to ...

The US Food and Drug Administration (FDA) has removed the clinical hold on a trial of Cialis (tadalafil) by Sanofi's consumer ...

Skyrizi had an estimated national TV ad spend of $367.7 million — the highest ad spend of any brand in the top 10.

Three years later, health and beauty brand L’Oreal acquired a majority ... but the company also develops over-the-counter medication as well. Sanofi now covers seven major therapeutic areas ...

Sanofi’s (SNY) said FDA lifted a hold on a trial to test over-the-counter use of its Eli-Lilly (LLY)-partnered erectile ...

Sanofi's Consumer Healthcare division, Opella, announced that the U.S. Food and Drug Administration has lifted a clinical hold on its ...

For those of us who want the best, strongest and most effective ingredients, retinol is an absolute must. And while you can ...

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

The strategic move diversifies and strengthens Bridges’ portfolio of specialty OTC brands, increasing the Company’s scale and positioning Bridges for accelerated organic growth and further add ...

CHATTANOOGA, Tenn., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Bridges Consumer Healthcare LLC ("Bridges” or the "Company”), a consumer healthcare platform made up of nine over-the-counter ("OTC”) and personal ...